- Home
- PTHL vs NUAI Comparison
PTHL vs NUAI Comparison
Compare PTHL & NUAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTHL
- NUAI
- Stock Information
- Founded
- PTHL 1998
- NUAI N/A
- Country
- PTHL China
- NUAI United States
- Employees
- PTHL N/A
- NUAI N/A
- Industry
- PTHL
- NUAI Oil & Gas Production
- Sector
- PTHL
- NUAI Energy
- Exchange
- PTHL Nasdaq
- NUAI Nasdaq
- Market Cap
- PTHL 10.0M
- NUAI 10.4M
- IPO Year
- PTHL 2024
- NUAI N/A
- Fundamental
- Price
- PTHL $0.63
- NUAI $4.55
- Analyst Decision
- PTHL
- NUAI
- Analyst Count
- PTHL 0
- NUAI 0
- Target Price
- PTHL N/A
- NUAI N/A
- AVG Volume (30 Days)
- PTHL 111.6K
- NUAI 55.9M
- Earning Date
- PTHL 01-01-0001
- NUAI 11-14-2025
- Dividend Yield
- PTHL N/A
- NUAI N/A
- EPS Growth
- PTHL N/A
- NUAI N/A
- EPS
- PTHL N/A
- NUAI N/A
- Revenue
- PTHL $448,196.00
- NUAI $718,761.00
- Revenue This Year
- PTHL N/A
- NUAI N/A
- Revenue Next Year
- PTHL N/A
- NUAI N/A
- P/E Ratio
- PTHL N/A
- NUAI N/A
- Revenue Growth
- PTHL N/A
- NUAI 14.80
- 52 Week Low
- PTHL $0.51
- NUAI $0.32
- 52 Week High
- PTHL $32.00
- NUAI $12.29
- Technical
- Relative Strength Index (RSI)
- PTHL 31.21
- NUAI 78.40
- Support Level
- PTHL $0.55
- NUAI $2.90
- Resistance Level
- PTHL $0.70
- NUAI $4.30
- Average True Range (ATR)
- PTHL 0.06
- NUAI 0.70
- MACD
- PTHL 0.09
- NUAI 0.20
- Stochastic Oscillator
- PTHL 29.13
- NUAI 95.05
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.
About NUAI New Era Energy & Digital Inc. Common Stock
New Era Energy & Digital Inc is engaged into a fully integrated energy supplier delivering next-gen digital infrastructure and power assets. The company provides turnkey solutions to speed up data center deployment and reduce costs. The company focuses on future-proofing infrastructure for hyperscale, enterprise, and edge operators. The company provide integrated energy and digital solutions to support accelerating AI infrastructure deployment and optimize data center investments.